CD8A and neoplasm: In addition, in a bladder tumor model, treatment with bisdesmethoxycurcumin significantly decreased the level of PD-1 expression on the surface of CD8+ T lymphocytes, and simultaneously elevated IFN-γ and granzyme B release was detected, thus ultimately significantly inhibiting tumor development and enhancing survival.